AMAG Pharmaceuticals, Inc. (AMAG) Tops Q4 EPS by 25c

March 5, 2012 4:05 PM EST
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q4 EPS of ($0.87), $0.25 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $14.72 million.

For earnings history and earnings-related data on AMAG Pharmaceuticals, Inc. (AMAG) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings